Portfolio Companies

Cempra
(NASDAQ: CEMP)
Chapel Hill, NC
Developing drugs for difficult-to-treat and drug-resistant bacterial infections, including community-acquired bacterial pneumonia and MRSA infections
Horizon
(NASDAQ: HZNP)
Deerfield, IL
Identifying, developing, acquiring and commercializing drugs to target unmet therapeutic needs in arthritis, pain, inflammatory and rare diseases
INNOVUS
(NASDAQ: INNV)
La Jolla, CA
Commercializing, licensing and developing prescription and non-prescription pharmaceutical focused on sexual health and other therapeutic categories
SEMPRAE MERGED WITH INNOVUS IN DECEMBER 2013
Insmed
(NASDAQ: INSM)
Monmouth Jct., NJ
Developing inhaled therapeutics to treat chronic respiratory infections, with additional programs for treatment of neuromuscular and metabolic disorders
TRANSAVE MERGED WITH INSMED IN DECEMBER 2010
Intact
Wayne, PA
Medical device company developing a novel endovascular stapling device designed to optimize peripheral angioplasty results for the treatment of peripheral artery disease (PAD)
Neuronetics
Malvern, PA
Developing and commercializing Transcranial Magnetic Stimulation, a noninvasive medical technology, to treat psychiatric and neurological disorders
NovaSom
Glen Burnie, MD
Provides at-home diagnostic testing of obstructive sleep apnea (OSA) as an alternative to in-laboratory sleep studies
NYDHA
New York, NY
Funding early and growth stage digital health and healthcare IT companies developing cutting edge technologies in care coordination, patient engagement, analytics and message alerts
RainDance
Billerica, MA
Provider of innovative single molecule and single cell analysis solutions that enable discovery of common and rare regions of genomic interest. Proprietary microdroplet technology has broad applications in genomic research, development of clinical diagnostics, compound screening, and biomarker detection
Rapid Micro BioSystems
Lowell, MA
Commercializing automated rapid testing to detect microbiological contamination in the manufacture of pharmaceutical and personal care products
Tarsa
Philadelphia, PA
Developing an oral formulation of calcitonin for the treatment of osteoporosis
TearScience
Morrisville, NC
Commercializing a novel, office-based medical device to identify, diagnose and treat Meibomian Gland Dysfunction, the leading cause of dry eye
TelaBio
Malvern, PA
Developing and commercializing innovative biosurgical products for use in advanced surgical reconstruction procedures.